Pimavanserin is a member of the class of ureas in which three of the four hydrogens are replaced by 4-fluorobenzyl, 1-methylpiperidin-4-yl, and 4-(isopropyloxy)benzyl groups. It is grouped under the following drug class(es): Psychotropic agents. Its therapeutic use is listed as antipsychotics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Nuplazid and N-(4-Fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N’-(4-(2-methylpropyloxy)phenylmethyl) carbamide. Its PubChem CID is 10071196.
Pimavanserin
| CAS No | 706779-91-1 |
|---|---|
| Molecular Formula | C25H34FN3O2 |
| Molecular Weight | 427.6 g/mol |
| Synonyms | 1-[(4-fluorophenyl)methyl]-1-(1-methylpiperidin-4-yl)-3-[[4-(2-methylpropoxy)phenyl]methyl]urea |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Pimavanserin is a member of the class of ureas in which three of the four hydrogens are replaced by 4-fluorobenzyl, 1-methylpiperidin-4-yl, and 4-(isopropyloxy)benzyl groups.
The listed CAS number is 706779-91-1.
The listed molecular formula is C25H34FN3O2.
The listed molecular weight is 427.6 g/mol.
1-[(4-fluorophenyl)methyl]-1-(1-methylpiperidin-4-yl)-3-[[4-(2-methylpropoxy)phenyl]methyl]urea.
The source lists Nuplazid and N-(4-Fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide.